(19)
(11) EP 4 798 219 A1

(12)

(43) Date of publication:
02.09.2026 Bulletin 2026/36

(21) Application number: 24883337.8

(22) Date of filing: 24.10.2024
(51) International Patent Classification (IPC): 
A61K 35/545(2015.01)
A61P 25/00(2006.01)
A61K 9/08(2006.01)
A61B 5/11(2006.01)
(52) Cooperative Patent Classification (CPC):
A61P 25/00; A61K 9/0043; A61K 9/0085; A61B 5/369; A61B 5/165; A61B 5/4848; A61B 5/0215; A61B 5/0071; C12N 5/0623; C12N 2500/34; C12N 2533/52; C12N 2533/32; C12N 2501/115; C12N 2501/11; C12N 2501/415; C12N 5/0667; C12N 2501/01; C12N 2501/135; C12N 2501/13; A61K 35/30
(86) International application number:
PCT/US2024/052831
(87) International publication number:
WO 2025/090778 (01.05.2025 Gazette 2025/18)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC ME MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA
Designated Validation States:
GE KH MA MD TN

(30) Priority: 24.10.2023 US 202363545438 P
25.09.2024 US 202463698996 P

(71) Applicant: University of Maryland, Baltimore
Baltimore, MD 21201 (US)

(72) Inventor:
  • JIA, Xiaofeng
    Baltimore, MD 21201 (US)

(74) Representative: Schwarz & Partner Patentanwälte GmbH 
Patentanwälte Wipplingerstraße 30
1010 Wien
1010 Wien (AT)

   


(54) METABOLICALLY GLYCOENGINEERED STEM CELLS AND METHODS OF USE THEREOF